{"id":"https://openalex.org/W2740715217","doi":"https://doi.org/10.1158/1538-7445.am2017-ct162","title":"Abstract CT162: Pre-specified interim analysis in a prospective, randomized phase II trial of trastuzumab vs trastuzumab + NeuVax to prevent breast cancer recurrence in HER2+ breast cancer patients","display_name":"Abstract CT162: Pre-specified interim analysis in a prospective, randomized phase II trial of trastuzumab vs trastuzumab + NeuVax to prevent breast cancer recurrence in HER2+ breast cancer patients","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2740715217","doi":"https://doi.org/10.1158/1538-7445.am2017-ct162","mag":"2740715217"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-ct162","doi":"https://doi.org/10.1158/1538-7445.am2017-ct162","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-ct162","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110393574","display_name":"Kaitlin M. Peace","orcid":"https://orcid.org/0000-0003-4933-9614","observed_orcids":["https://orcid.org/0000-0003-4933-9614"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlin M. Peace","raw_affiliation_strings":["1San Antonio Military Medical Center, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1San Antonio Military Medical Center, San Antonio, TX;","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014713051","display_name":"Jennifer Keating Litton","orcid":"https://orcid.org/0000-0001-8390-4985","observed_orcids":["https://orcid.org/0000-0001-8390-4985"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer K. Litton","raw_affiliation_strings":["2The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027764647","display_name":"Rashmi Krishna Murthy","orcid":"https://orcid.org/0000-0002-0103-4718","observed_orcids":["https://orcid.org/0000-0002-0103-4718"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rashmi Murthy","raw_affiliation_strings":["2The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065391640","display_name":"Timothy J. Vreeland","orcid":"https://orcid.org/0000-0003-4593-7502","observed_orcids":["https://orcid.org/0000-0003-4593-7502"]},"institutions":[{"id":"https://openalex.org/I1335269842","display_name":"Womack Army Medical Center","ror":"https://ror.org/00ajwxp03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330347796","https://openalex.org/I1335269842","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Vreeland","raw_affiliation_strings":["3Womack Army Medical Center, Fort Bragg, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Womack Army Medical Center, Fort Bragg, NC;","institution_ids":["https://openalex.org/I1335269842"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035547335","display_name":"Diane F. Hale","orcid":"https://orcid.org/0000-0003-1800-140X","observed_orcids":["https://orcid.org/0000-0003-1800-140X"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane F. Hale","raw_affiliation_strings":["1San Antonio Military Medical Center, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1San Antonio Military Medical Center, San Antonio, TX;","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112394718","display_name":"Doreen O. Jackson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doreen O. Jackson","raw_affiliation_strings":["1San Antonio Military Medical Center, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1San Antonio Military Medical Center, San Antonio, TX;","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John S. Berry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John S. Berry","raw_affiliation_strings":["4Washington University, St Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Washington University, St Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108356086","display_name":"Alfred Francois Trappey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alfred F. Trappey","raw_affiliation_strings":["1San Antonio Military Medical Center, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1San Antonio Military Medical Center, San Antonio, TX;","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074845988","display_name":"Garth S. Herbert","orcid":"https://orcid.org/0000-0002-6415-1612","observed_orcids":["https://orcid.org/0000-0002-6415-1612"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garth S. Herbert","raw_affiliation_strings":["1San Antonio Military Medical Center, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1San Antonio Military Medical Center, San Antonio, TX;","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050537038","display_name":"Guy Travis Clifton","orcid":"https://orcid.org/0000-0001-5962-3876","observed_orcids":["https://orcid.org/0000-0001-5962-3876"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guy T. Clifton","raw_affiliation_strings":["1San Antonio Military Medical Center, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1San Antonio Military Medical Center, San Antonio, TX;","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111863744","display_name":"Mark O. Hardin","orcid":"https://orcid.org/0000-0001-8210-3115","observed_orcids":["https://orcid.org/0000-0001-8210-3115"]},"institutions":[{"id":"https://openalex.org/I1330654748","display_name":"Madigan Army Medical Center","ror":"https://ror.org/01sfyq865","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330347796","https://openalex.org/I1330654748","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark O. Hardin","raw_affiliation_strings":["5Madigan Army Medical Center, Tacoma, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Madigan Army Medical Center, Tacoma, WA;","institution_ids":["https://openalex.org/I1330654748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044161354","display_name":"George Earl Peoples","orcid":"https://orcid.org/0000-0001-7118-8205","observed_orcids":["https://orcid.org/0000-0001-7118-8205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George E. Peoples","raw_affiliation_strings":["6Cancer Vaccine Development Program, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Cancer Vaccine Development Program, San Antonio, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Mittendorf","raw_affiliation_strings":["2The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"CT162","last_page":"CT162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9290000200271606},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/peptide-vaccine","display_name":"peptide vaccine","score":0.7070000171661377},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.8289999961853027},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/breast-cancer-recurrence-prevention","display_name":"breast cancer recurrence prevention","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7739999890327454},{"id":"https://openalex.org/keywords/ejection-fraction","display_name":"ejection fraction","score":0.8339999914169312},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.34599998593330383},{"id":"https://openalex.org/keywords/interim-analysis","display_name":"interim analysis","score":0.39100000262260437},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.49399998784065247},{"id":"https://openalex.org/keywords/node-positive-disease","display_name":"node-positive disease","score":0.5920000076293945},{"id":"https://openalex.org/keywords/high-risk-recurrence","display_name":"high-risk recurrence","score":0.3700000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9035580158233643},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8317208290100098},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6191027164459229},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6088595986366272},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6063887476921082},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6054028868675232},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5655701160430908},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.5081956386566162},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4730241298675537},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4109414219856262},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40776169300079346},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3516930341720581}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-ct162","doi":"https://doi.org/10.1158/1538-7445.am2017-ct162","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-ct162","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2588751715","https://openalex.org/W2898596272","https://openalex.org/W2944303325","https://openalex.org/W1885514222","https://openalex.org/W2330056985","https://openalex.org/W1976634397","https://openalex.org/W2915498065","https://openalex.org/W2240809995","https://openalex.org/W2121198752","https://openalex.org/W2151050919"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"The":[2,360],"HER2-targeted":[3,37],"monoclonal":[4],"antibody,":[5],"trastuzumab":[6,469,471],"(Tz),":[7],"is":[8,40,61,370],"standard":[9],"of":[10,58,192,213,223,266,362,385,396,468,487],"care":[11],"(SOC)":[12],"for":[13,125,200,491],"HER2-positive":[14],"(HER2+)":[15],"breast":[16,476,481],"cancer":[17,477,482],"(BCa)":[18],"and":[19,43,93,159,172,181,248,253,258,299,308,349,364,373,403,407],"has":[20],"been":[21],"shown":[22,29],"to":[23,68,99,169,334,390,393,474],"reduce":[24],"recurrence.":[25],"We":[26,75,387],"have":[27,45,274],"previously":[28],"that":[30,63],"NeuVax":[31,173,193,473],"(E75":[32],"peptide":[33,38],"+":[34,472],"GM-CSF),":[35],"a":[36,65,82,462],"vaccine,":[39],"safe,":[41],"immunogenic,":[42],"may":[44,71],"synergistic":[46],"clinical":[47,408],"efficacy":[48],"when":[49],"combined":[50],"with":[51,117,141,162,209],"Tz.":[52],"Given":[53],"the":[54,96,109,175,185,210,221,224,267,306,374,383,411,488],"known":[55],"cardiac":[56,375],"toxicity":[57],"Tz,":[59],"there":[60,350],"concern":[62],"adding":[64],"HER2-directed":[66],"vaccine":[67,176,205],"Tz":[69,92,171,180,214,363,378],"therapy":[70,135],"exacerbate":[72],"this":[73,400],"effect.":[74],"are":[76,379],"currently":[77],"enrolling":[78],"patients":[79,483],"(pts)":[80],"in":[81,95,102,174,184,302,331,336,354,366,399,410,461,479],"multi-center,":[83],"prospective,":[84,463],"randomized,":[85],"single-blinded,":[86],"placebo-controlled":[87],"phase":[88,465],"II":[89,466],"trial":[90,467],"combining":[91],"Neuvax":[94,365],"adjuvant":[97],"setting":[98],"prevent":[100,475],"recurrence":[101,126,478],"HER2+":[103,120,367,480],"BCa":[104,115,368],"pts.":[105],"Here,":[106],"we":[107,273],"present":[108],"initial":[110],"safety":[111,254],"data.":[112],"Methods:":[113],"HLA-A2/A3+":[114],"pts":[116,226,277,369,398],"stage":[118],"I-III":[119],"disease":[121,144],"at":[122,246],"high":[123],"risk":[124],"(pts":[127],"not":[128,380],"achieving":[129],"complete":[130],"response":[131],"after":[132,155,220,264,415],"Tz-containing":[133,164],"neoadjuvant":[134],"or":[136,147,179,194,244,296],"those":[137],"undergoing":[138],"up-front":[139],"surgery":[140],"any":[142],"node-positive":[143],"if":[145,151],"ER/PR-":[146],"\u22654":[148],"positive":[149],"nodes":[150],"ER/PR+)":[152],"were":[153,167,256,283,291],"enrolled":[154,275],"SOC":[156],"surgery,":[157],"radiation":[158],"neo-adjuvant/adjuvant":[160],"chemotherapy":[161],"approved":[163],"regimen.":[165],"Pts":[166,189],"randomized":[168,464],"receive":[170],"group":[177,187,338],"(VG)":[178],"GM-CSF":[182,195],"only":[183],"control":[186],"(CG).":[188],"received":[190,227],"vaccinations":[191,203],"intradermally":[196],"every":[197,232],"3":[198],"weeks":[199],"6":[201,218,233],"total":[202],"(primary":[204],"series,":[206],"PVS)":[207],"starting":[208],"third":[211],"dose":[212],"maintenance":[215],"therapy.":[216],"Starting":[217],"months":[219],"completion":[222],"PVS,":[225],"four":[228],"booster":[229],"inoculations,":[230],"one":[231],"months.":[234],"Cardiac":[235],"ejection":[236],"fraction":[237],"(EF)":[238],"was":[239,262,327,351],"assessed":[240],"by":[241,382],"either":[242,337],"echo":[243],"MUGA":[245],"baseline":[247],"serially":[249],"during":[250],"treatment.":[251],"Demographic":[252],"data":[255],"collected":[257],"analyzed.":[259],"Safety":[260],"analysis":[261,414,460],"initiated":[263],"enrollment":[265],"50th":[268],"patient.":[269],"Results:":[270],"To":[271],"date,":[272],"50":[276],"(VG":[278],"n=22,":[279],"CG":[280,309],"n=28).":[281],"There":[282,290,326],"no":[284,292,300,328,352],"significant":[285,329],"clinicopathologic":[286],"differences":[287,301],"between":[288,305,356],"groups.":[289],"related":[293,303],"grade":[294],"4":[295],"5":[297],"toxicities":[298,304],"VG":[307],"(Grade":[310],"1:":[311],"96%":[312],"vs":[313,318,323,341,346,470],"98.5%;":[314],"Grade":[315,320],"2:":[316],"3.2%":[317],"1.5%;":[319],"3:":[321],"0.8%":[322],"0%,":[324],"p=0.14).":[325],"reduction":[330],"EF":[332],"pre-":[333],"post-treatment":[335],"(VG:":[339],"61.1\u00b15.4%":[340],"60.1\u00b14.8%,":[342],"p=0.55;":[343],"CG:":[344],"62.3\u00b15.7%":[345],"61.9\u00b14.0%,":[347],"p=0.74)":[348],"difference":[353],"change":[355],"groups":[357],"(p=0.54).":[358],"Conclusion:":[359],"combination":[361],"well":[371],"tolerated":[372],"effects":[376],"from":[377],"worsened":[381],"addition":[384],"NeuVax.":[386],"will":[388,404],"continue":[389],"enroll":[391],"up":[392],"our":[394],"goal":[395],"100":[397],"ongoing":[401],"trial,":[402],"report":[405],"immunologic":[406],"outcomes":[409],"planned":[412],"primary":[413],"24-months":[416],"follow-up.":[417],"Citation":[418],"Format:":[419],"Kaitlin":[420],"M.":[421],"Peace,":[422],"Jennifer":[423],"K.":[424],"Litton,":[425],"Rashmi":[426],"Murthy,":[427],"Timothy":[428],"J.":[429],"Vreeland,":[430],"Diane":[431],"F.":[432,441],"Hale,":[433],"Doreen":[434],"O.":[435,450],"Jackson,":[436],"John":[437],"S.":[438,444],"Berry,":[439],"Alfred":[440],"Trappey,":[442],"Garth":[443],"Herbert,":[445],"Guy":[446],"T.":[447],"Clifton,":[448],"Mark":[449],"Hardin,":[451],"George":[452],"E.":[453],"Peoples,":[454],"Elizabeth":[455],"A.":[456],"Mittendorf.":[457],"Pre-specified":[458],"interim":[459],"[abstract].":[484],"In:":[485],"Proceedings":[486],"American":[489],"Association":[490],"Cancer":[492,505],"Research":[493],"Annual":[494],"Meeting":[495],"2017;":[496],"2017":[497],"Apr":[498],"1-5;":[499],"Washington,":[500],"DC.":[501],"Philadelphia":[502],"(PA):":[503],"AACR;":[504],"Res":[506],"2017;77(13":[507],"Suppl):Abstract":[508],"nr":[509],"CT162.":[510],"doi:10.1158/1538-7445.AM2017-CT162":[511]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-08-08T00:00:00"}